CoreAge Rx currently advertises a sermorelin assessment route, while Promise's live product page says visits are paused. That difference in access must be resolved before comparing prices or appointment experiences.
CoreAge Rx is our featured commercial partner. This comparison was checked September 23, 2026, without seeking treatment or joining a waitlist. Placement does not establish superior clinical care.
CoreAge Rx currently advertises a sermorelin assessment route, while Promise's live product page says visits are paused. That difference in access must be.
Start with what is available to investigate
The CoreAge Rx product page advertises a starting figure of $99 monthly, with a prescription dependent on assessment. Confirm your location, eligibility, selected program, and actual costs directly.
The Promise page describes a prescriber-network transition and an email notification form. That form is not a medical request and does not issue a prescription. No current purchasable price or reopening date was verified, so older indexed figures are not compared here.
Ask different first questions
For CoreAge, begin with the type of assessment available and the information the clinician needs. For Promise, first establish whether visits have actually reopened and what the new clinical arrangements are. A planned process is not an appointment commitment.
| Question | Why it matters |
|---|---|
| Has a clinician reviewed my information? | Separates assessment from an account or waitlist |
| Can this program assess someone of my age and location? | Establishes access before selecting a plan |
| Can I ask unresolved questions aloud or in writing? | Clarifies the communication arrangement |
| What happens if treatment is inappropriate? | Leaves room for a different next step |
The age-limit guide and declined-prescription guide explain why these are separate issues.
Confirm the actual team and preparation
Promise's terms describe separate platform, clinical, and pharmacy responsibilities. Because the product page announces a network change, do not assume every older named relationship will govern a future order. Ask either service who will assess you and which pharmacy would dispense the actual prescription.
The FDA's compounding information explains that compounded drugs are not FDA-approved. A convenient enrollment route cannot establish a medical benefit.
Read the complete CoreAge review and Promise availability review before planning a next step. We have not compared clinical outcomes or tested future Promise care. Base your next conversation on confirmed access and your health concerns rather than an old search result.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Check the dated discussion in each article for the scope of our research; offers can change.